December 28, 2016
Sanofi sues Novo Nordisk over diabetes drug in the U.S.
France’s Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that Sanofi insulin drugs would no longer be available for many U.S. patients so it could promote its competing drug.
